HOME >> BIOLOGY >> NEWS
Northeastern University and Massachusetts Biotechnology Council to host drug discovery day

WHO: The Massachusetts Biotechnology Council (MBC) Drug Discovery Committee and Northeastern University invite you to a new event in drug discovery technology. With the variety of new tools and knowledge available today to more rapidly develop advanced therapies, we have the "critical mass" in the Boston area to lead the world in drug discovery.

WHAT: Alexandros Makriyannis, PhD, Behrakis Trustee Chair in Pharmaceutical Biotechnology and Director, The Center for Drug Discovery, Northeastern University. Dr. Makriyannis comes to Northeastern this fall after 30 years at University of Connecticut and will continue his work on novel medications, drug mechanisms of action, and new therapeutic drug technologies.

Abbie Celniker, PhD, Senior Vice President of R & D Strategy and Operations, Millennium Pharmaceuticals, Inc. (MPI). In this role, Dr. Celniker is responsible for the oversight of the pipeline portfolio and project management activities at MPI. Prior to joining MPI, Dr. Celniker was the Assistant Vice President of Biotherapeutic Research Technologies at the Genetics Institute division of Wyeth Ayerst Research and prior to that was a Senior Scientist/Associate Director in the Medicinal and Analytical Chemistry department at Genentech, Inc.

WHERE: Monday, October 18, 2004 1 pm to 7 pm
Northeastern University, Curry Student Center

WHEN: 1:00 7:00 pm
1:00 Registration Opens
1:30 First Keynote - Alexandros Makriyannis
2:15 Poster Session Opens
4:30 Second Keynote - Abbie Celniker

TO ATTEND: E-mail your name, title and company to register@massbio.org. Include 10/18 Drug Discovery in the subject line.
Contact Lisa Woods at the MBC with questions at 617-577-8198 x207.


'"/>

Contact: Steve Sylven
ss@ur.neu.edu
617-373-7424
Northeastern University
14-Oct-2004


Page: 1

Related biology news :

1. New monkey discovered in Northeastern India
2. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
3. A study by the MUHC and McGill University opens a new door to understanding cancer
4. Biologists at Tufts University discover 1 reason why chromosomes break, often leading to cancer
5. $9M grant awarded to University of Cincinnati for bipolar disorder research
6. University of Leeds strengthens China links in membrane and neurobiology
7. University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.
8. Manchester University helps with pharaoh DNA analysis
9. University of Cincinnati receives $1.7M to research molecular treatment of brain injury
10. University of Arizona launches major scientific research initiative at Biosphere 2
11. Link between obesity and enlarged heart discovered by University of Arizona researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/19/2020)... ... June 18, 2020 , ... ... with Software for Data Decisions,” for pharmaceutical and biotech executives, laboratory managers, ... automate cutting-edge scientific instruments and laboratory equipment from dozens of manufacturers into ...
(Date:6/13/2020)... ... June 11, 2020 , ... Bode Technology (Bode), ... its forensic genealogy team. Bode’s Forensic Genealogy Service (FGS) continues to ... DNA analysis methods. The team has added experienced genealogists, each having over a ...
(Date:6/11/2020)... ... , ... Superior Controls, Inc. , an E Technologies Company and leading ... sciences industry, is pleased to announce the recent hiring of Ray Boudreau, who will ... Hampshire office. In his new role, Boudreau will use his extensive experience with ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... 29, 2020 , ... MedShift , a leading medical ... many obstacles created as a result of COVID-19. As a provider at the ... practices and medical manufacturers by expanding access to device offerings, technology services, and ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda ... treating cancer, today announced the company has entered a license agreement with Roswell ... provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a novel ...
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen Pharmaceuticals Inc., announced today ... 22-24 during the American Association for Cancer Research Virtual meeting. One poster describes ... consistent single agent activity in KEAP1 mutant tumor models of NSCLC. ...
(Date:6/11/2020)... ... June 09, 2020 , ... TRX Systems, developer of NEON® ... Solution, a highly accurate, contact tracing solution for identification of employees who may ... core disease control measure, is a key strategy for preventing further spread of ...
Breaking Biology Technology:
Cached News: